134 related articles for article (PubMed ID: 27471839)
1. A Highly Predictive Model for Diagnosis of Colorectal Neoplasms Using Plasma MicroRNA: Improving Specificity and Sensitivity.
Carter JV; Roberts HL; Pan J; Rice JD; Burton JF; Galbraith NJ; Eichenberger MR; Jorden J; Deveaux P; Farmer R; Williford A; Kanaan Z; Rai SN; Galandiuk S
Ann Surg; 2016 Oct; 264(4):575-84. PubMed ID: 27471839
[TBL] [Abstract][Full Text] [Related]
2. Circulating Serum miRNAs as Diagnostic Markers for Colorectal Cancer.
Zekri AR; Youssef AS; Lotfy MM; Gabr R; Ahmed OS; Nassar A; Hussein N; Omran D; Medhat E; Eid S; Hussein MM; Ismail MY; Alenzi FQ; Bahnassy AA
PLoS One; 2016; 11(5):e0154130. PubMed ID: 27135244
[TBL] [Abstract][Full Text] [Related]
3. A Fecal MicroRNA Signature by Small RNA Sequencing Accurately Distinguishes Colorectal Cancers: Results From a Multicenter Study.
Pardini B; Ferrero G; Tarallo S; Gallo G; Francavilla A; Licheri N; Trompetto M; Clerico G; Senore C; Peyre S; Vymetalkova V; Vodickova L; Liska V; Vycital O; Levy M; Macinga P; Hucl T; Budinska E; Vodicka P; Cordero F; Naccarati A
Gastroenterology; 2023 Sep; 165(3):582-599.e8. PubMed ID: 37263306
[TBL] [Abstract][Full Text] [Related]
4. Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer.
Shi YJ; Fang YX; Tian TG; Chen WP; Sun Q; Guo FQ; Gong PQ; Li CM; Wang H; Hu ZQ; Li XX
J Transl Med; 2023 Jun; 21(1):421. PubMed ID: 37386465
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of circulating microRNAs according to severity of colorectal neoplasia.
Ho GYF; Jung HJ; Schoen RE; Wang T; Lin J; Williams Z; Weissfeld JL; Park JY; Loudig O; Suh Y
Transl Res; 2015 Sep; 166(3):225-232. PubMed ID: 25770825
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as specific biomarkers for breast cancer detection.
Ng EK; Li R; Shin VY; Jin HC; Leung CP; Ma ES; Pang R; Chua D; Chu KM; Law WL; Law SY; Poon RT; Kwong A
PLoS One; 2013; 8(1):e53141. PubMed ID: 23301032
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a predictive model for detection of colorectal cancer in primary care by analysis of complete blood counts: a binational retrospective study.
Kinar Y; Kalkstein N; Akiva P; Levin B; Half EE; Goldshtein I; Chodick G; Shalev V
J Am Med Inform Assoc; 2016 Sep; 23(5):879-90. PubMed ID: 26911814
[TBL] [Abstract][Full Text] [Related]
8. Discovery and Validation of Circulating Biomarkers of Colorectal Adenoma by High-Depth Small RNA Sequencing.
Roberts BS; Hardigan AA; Moore DE; Ramaker RC; Jones AL; Fitz-Gerald MB; Cooper GM; Wilcox CM; Kimberly RP; Myers RM
Clin Cancer Res; 2018 May; 24(9):2092-2099. PubMed ID: 29490987
[No Abstract] [Full Text] [Related]
9. Cancer-specific risk prediction with a serum microRNA signature.
Raut JR; Bhardwaj M; Schöttker B; Holleczek B; Schrotz-King P; Brenner H
Cancer Sci; 2024 Jun; 115(6):2049-2058. PubMed ID: 38523358
[TBL] [Abstract][Full Text] [Related]
10. A case-controlled validation study of a blood-based seven-gene biomarker panel for colorectal cancer in Malaysia.
Yip KT; Das PK; Suria D; Lim CR; Ng GH; Liew CC
J Exp Clin Cancer Res; 2010 Sep; 29(1):128. PubMed ID: 20846378
[TBL] [Abstract][Full Text] [Related]
11. A novel serum metabolomics-based diagnostic approach for colorectal cancer.
Nishiumi S; Kobayashi T; Ikeda A; Yoshie T; Kibi M; Izumi Y; Okuno T; Hayashi N; Kawano S; Takenawa T; Azuma T; Yoshida M
PLoS One; 2012; 7(7):e40459. PubMed ID: 22792336
[TBL] [Abstract][Full Text] [Related]
12. A proteomic classifier panel for early screening of colorectal cancer: a case control study.
Hua H; Wang T; Pan L; Du X; Xia T; Fa Z; Gu L; Gao F; Yu C; Gao F; Liao L; Shen Z
J Transl Med; 2024 Feb; 22(1):188. PubMed ID: 38383428
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of microbial markers for risk prediction of colorectal neoplasia.
Yu L; Zhao G; Wang L; Zhou X; Sun J; Li X; Zhu Y; He Y; Kofonikolas K; Bogaert D; Dunlop M; Zhu Y; Theodoratou E; Li X
Br J Cancer; 2022 May; 126(9):1318-1328. PubMed ID: 35292756
[TBL] [Abstract][Full Text] [Related]
14. Plasma metabolites associated with colorectal cancer: A discovery-replication strategy.
Geijsen AJMR; Brezina S; Keski-Rahkonen P; Baierl A; Bachleitner-Hofmann T; Bergmann MM; Boehm J; Brenner H; Chang-Claude J; van Duijnhoven FJB; Gigic B; Gumpenberger T; Hofer P; Hoffmeister M; Holowatyj AN; Karner-Hanusch J; Kok DE; Leeb G; Ulvik A; Robinot N; Ose J; Stift A; Schrotz-King P; Ulrich AB; Ueland PM; Kampman E; Scalbert A; Habermann N; Gsur A; Ulrich CM
Int J Cancer; 2019 Sep; 145(5):1221-1231. PubMed ID: 30665271
[TBL] [Abstract][Full Text] [Related]
15. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
16. Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer.
Vychytilova-Faltejskova P; Radova L; Sachlova M; Kosarova Z; Slaba K; Fabian P; Grolich T; Prochazka V; Kala Z; Svoboda M; Kiss I; Vyzula R; Slaby O
Carcinogenesis; 2016 Oct; 37(10):941-950. PubMed ID: 27485599
[TBL] [Abstract][Full Text] [Related]
17. A panel of microRNA signature in serum for colorectal cancer diagnosis.
Zhu M; Huang Z; Zhu D; Zhou X; Shan X; Qi LW; Wu L; Cheng W; Zhu J; Zhang L; Zhang H; Chen Y; Zhu W; Wang T; Liu P
Oncotarget; 2017 Mar; 8(10):17081-17091. PubMed ID: 28177881
[TBL] [Abstract][Full Text] [Related]
18. Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
Carter JV; Galbraith NJ; Yang D; Burton JF; Walker SP; Galandiuk S
Br J Cancer; 2017 Mar; 116(6):762-774. PubMed ID: 28152545
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-125b promotes tumor growth and suppresses apoptosis by targeting DRAM2 in retinoblastoma.
Bai S; Tian B; Li A; Yao Q; Zhang G; Li F
Eye (Lond); 2016 Dec; 30(12):1630-1638. PubMed ID: 27518550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
